# Running royalty vs lump sum: which payment structure suits an Indian MSME

URL: https://zernyxhub.com/blog/running-royalty-vs-lump-sum
Author: Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP
Published: 2026-10-28
Category: Licensing

> Running royalty vs lump sum for a technology license: a decision table, a worked breakeven in rupees, TDS rules and the clauses an Indian MSME should insist on.

**Short answer:** A running royalty is a percentage of each period's sales, paid only while you sell. A lump sum is a fixed amount, whatever you sell. An MSME with uncertain sales and tight cash is usually better off with a royalty. A lump sum pays off only when you are confident sales will pass the breakeven figure.

Every technology licence answers one money question: do you pay the licensor now, or as you sell? A running royalty ties the payment to your sales. A lump sum fixes it on day one. Most Indian deals mix the two, with an upfront fee and a smaller royalty, but the balance between them decides how much risk your company carries.

For an MSME the honest default is to lean on the royalty. Cash is scarcest before the first sale, and a royalty costs nothing until money comes in. That changes once you have firm orders or a clear market, and this post shows how to tell which side of the line you are on.

## What do the two structures mean?

A **running royalty** is a recurring payment calculated on what you sell: usually a percentage of net sales, sometimes a fixed amount per unit. You report sales each quarter or year and pay against that report. NIT Karnataka's [Innovation and Entrepreneurship Policy (2024)](https://step.nitk.ac.in/Innovation%20policy%20and%20proceedure.pdf) is typical: an initial technology fee at signing, then royalties paid quarterly or annually against audited sales statements.

A **lump sum** is a fixed price for the licence. You pay it at signing or in agreed instalments, and you owe nothing more however much you sell. When the lump sum is the whole price for the full term, people call it a fully paid-up licence.

Between them sits the common hybrid: an upfront fee plus a lower running royalty. Indian institutions often insist on it. NIT Calicut's [Technology Transfer Policy 2024](https://nitc.ac.in/imgserver/uploads/attachments/Ed__9fcf1f03-411d-4804-bbef-6058d6c0b292_.pdf) says an upfront lump sum and royalty together is the choice it proposes, and that a royalty-only arrangement is generally not recommended. Our guide to the [upfront license fee](https://zernyxhub.com/blog/upfront-license-fee) covers how that first payment is set.

**Running royalty or lump sum?**
Running royalty:
- Paid only as you sell
- Licensor shares your sales risk
- Needs sales reports and audits
- Costs more if sales are large
Lump sum:
- Fixed cost, paid up front or in parts
- You carry all the sales risk
- No reporting after payment
- Cheaper if sales beat breakeven
Uncertain sales favour the royalty; confident volumes favour the lump sum

## Which one suits your company? A decision table

Use the table as a first filter. If most of your answers fall in one column, start your negotiation there.

| Question | Points to a running royalty | Points to a lump sum |
|---|---|---|
| How certain are your sales in years 1 to 3? | Uncertain, new market | Firm orders or an existing channel |
| How much cash can you commit at signing? | Little; working capital is tight | Enough to pay without hurting operations |
| What TRL is the technology at? | TRL 1 to 6, more development ahead | TRL 7 and above, close to sale |
| Can you report sales cleanly for one product? | Yes, it is a separate SKU or line | No, it is buried inside a larger product |
| How long will you sell it? | Short or unknown | Many years, well past breakeven |
| Do you want the licensor engaged after signing? | Yes, a royalty keeps them interested | No, you need little support |

Two rows deserve more weight than the rest. If you cannot separate the licensed product's sales from the rest of your business, a royalty will cause disputes every year, and a lump sum (or a per-unit royalty) is cleaner. And if the technology is early, a lump sum means paying full price for something that may never reach the market.

## A worked example: where is the breakeven?

The numbers below are an illustration, not a real deal.

An MSME in Pune wants to license a coating process. The licensor offers two options for a ten-year licence:

- Option A: ₹30 lakh lump sum, paid at signing.
- Option B: 4% running royalty on net sales of the coated product, nothing upfront.

The breakeven is the lump sum divided by the royalty rate: ₹30 lakh ÷ 4% = ₹7.5 crore of cumulative net sales. Below ₹7.5 crore over the ten years, Option B costs less. Above it, Option A does.

| Year | Net sales of coated product | Royalty at 4% (Option B) | Cumulative royalty |
|---|---|---|---|
| 1 | ₹40 lakh | ₹1.6 lakh | ₹1.6 lakh |
| 2 | ₹90 lakh | ₹3.6 lakh | ₹5.2 lakh |
| 3 | ₹1.5 crore | ₹6.0 lakh | ₹11.2 lakh |
| 4 | ₹2.0 crore | ₹8.0 lakh | ₹19.2 lakh |
| 5 | ₹2.4 crore | ₹9.6 lakh | ₹28.8 lakh |

On this plan the royalty catches up with the lump sum early in year 6, after ₹7.2 crore of sales. If you believe the plan, the lump sum is cheaper over ten years. If year 1 slips or the market is half the size, the royalty wins by a wide margin. Also count what the ₹30 lakh would have earned in your business during those five years; money paid at signing is worth more than the same rupees paid in year 5.

**Option B royalty against a ₹30 lakh lump sum**
- Year 1, ₹1.6 lakh paid: On ₹40 lakh of sales
- Year 3, ₹11.2 lakh paid: Cumulative, on ₹2.8 crore of sales
- Year 5, ₹28.8 lakh paid: Cumulative, on ₹7.2 crore of sales
- Year 6, Breakeven passed: ₹7.5 crore of cumulative sales

A middle path often beats both. Ask for a smaller upfront fee, say ₹8 lakh, plus a 3% royalty. Or ask for a royalty that stops once total payments reach an agreed cap. A cap gives the licensor upside while capping your total cost, and it is easy to model.

## How does tax treat each structure?

For a resident licensor, TDS on royalty is 10% under [section 393(1) of the Income-tax Act, 2025](https://www.incometaxindia.gov.in/w/section-393-6), Table serial 6(iii), once payments to that licensor in the financial year cross ₹50,000. A lump sum paid for a licence of a patent, invention or process is normally treated as royalty as well, so plan TDS on both structures. The difference is timing: with a lump sum the whole deduction falls in one year; with a royalty it is spread across the years you sell.

GST applies to licence fees and royalty too. Our [GST and TDS guide](https://zernyxhub.com/blog/gst-tds-royalty-india) covers rates, invoices and foreign licensors. Whether your books treat a large lump sum as an expense or as an intangible asset written off over the licence term is a question for your chartered accountant, and it can change your reported profit in year 1 by a large amount.

## What should the agreement say?

Whichever structure you pick, the clauses decide what you actually pay.

For a running royalty, define the base precisely. "Net sales" should list what is deducted (GST, returns, trade discounts, freight) and say whether sales to a related company count at the invoice price or at market price. Set the reporting period, the payment date after each period, and the licensor's audit right, including who pays for an audit and how far back it can go. A minimum annual royalty is common in exclusive deals; if you accept one, tie it to a ramp-up so year 1 is low. Our [royalty rates guide](https://zernyxhub.com/blog/royalty-rates) explains what pushes the percentage up or down.

For a lump sum, write down what the payment buys: the full term, all fields, improvements or not, and whether it is refundable if the patent is refused or revoked. Pay in instalments linked to events you can verify, such as delivery of know-how documents or a successful trial batch. NIT Calicut, for example, allows the upfront fee in at most three instalments, with at least half at signing.

For either, check the exclusivity you are paying for. A lump sum for a non-exclusive licence is a fixed cost your competitors may pay too; for that trade-off, see [exclusive or non-exclusive licences](https://zernyxhub.com/blog/exclusive-licence).

## Common mistakes

- Comparing a lump sum with a royalty in nominal rupees only, without counting what the cash would earn in your business.
- Agreeing a royalty on "sales" with no definition, then arguing about it every year.
- Paying a large lump sum for a TRL 4 technology that still needs two years of work.
- Forgetting that TDS falls in the year you pay, which matters most with a single large payment.

One caveat on all of this: licensors with many licensees often have a fixed structure and little room to change it. Ask early whether the structure is negotiable, and spend your effort on the rate or the cap if it is not.

If you are still choosing which technology to license, [Zernyx Hub](https://www.zernyxhub.com) has mapped patents from universities across India, with AI business insight on each, including commercial applications. Shortlisting by application first makes the sales forecast behind your breakeven far more believable.

## Common questions

### What is the difference between a running royalty and a lump sum?

A running royalty is a percentage of net sales (or a fixed amount per unit) paid each quarter or year for as long as you sell the licensed product. A lump sum is a fixed amount agreed at signing and paid once or in instalments, whether you sell one unit or a million.

### Is TDS deducted on a lump-sum license fee in India?

Usually yes. Royalty paid to a resident attracts TDS at 10% under section 393(1) of the Income-tax Act, 2025, once the year's payments cross ₹50,000, and a lump sum paid for a licence of a patent, invention or process is normally treated as royalty. Confirm the classification of your payment with your chartered accountant.

### Will an Indian institution accept a lump sum instead of a royalty?

Some will, but many prefer both. NIT Calicut's 2024 Technology Transfer Policy proposes an upfront fee and royalty together and says a royalty-only arrangement is generally not recommended. Ask the institution which structures its policy allows before you model your offer.

### How do I work out the breakeven between a lump sum and a royalty?

Divide the lump sum by the royalty rate. A ₹30 lakh lump sum against a 4% royalty breaks even at ₹7.5 crore of cumulative net sales. Below that figure the royalty costs you less; above it the lump sum does.

---

Published by Zernyx Hub. More: https://zernyxhub.com/llms.txt
